In cluster of differentiation (CD)133-positive glioma cancer stem-like cells, which overexpress GLI1 [69], increased resistance to chemotherapeutic agents like temozolomide, carboplatin, paclitaxel and etoposide have been observed [92]. Here, GLI1 is linked to central nervous system cancer.